These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7502851)

  • 21. IL-6-deficient mice exhibit normal mucosal IgA responses to local immunizations and Helicobacter felis infection.
    Bromander AK; Ekman L; Kopf M; Nedrud JG; Lycke NY
    J Immunol; 1996 Jun; 156(11):4290-7. PubMed ID: 8666800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nasally administered cholera toxin A-subunit acts as a mucosal adjuvant.
    Campos EA; Namikoshi J; Maeba S; Yamamoto M; Fukumoto M; Yamamoto H
    J Oral Sci; 2003 Mar; 45(1):25-31. PubMed ID: 12816361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A two-codon mutant of cholera toxin lacking ADP-ribosylating activity functions as an effective adjuvant for eliciting mucosal and systemic cellular immune responses to peptide antigens.
    Lomada D; Gambhira R; Nehete PN; Guhad FA; Chopra AK; Peterson JW; Sastry KJ
    Vaccine; 2004 Dec; 23(4):555-65. PubMed ID: 15530705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced soluble production of cholera toxin B subunit in Escherichia coli by co-expression of SKP chaperones.
    Zhang Y; Qiao X; Yu X; Chen J; Hou L; Bi Z; Zheng Q; Hou J
    Protein Expr Purif; 2017 Oct; 138():1-6. PubMed ID: 28673733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of CTL by oral immunization.
    Enders GA
    Adv Exp Med Biol; 1995; 371B():1455-8. PubMed ID: 7502836
    [No Abstract]   [Full Text] [Related]  

  • 26. Importance of gastrointestinal ingestion and macromolecular antigens in the vein for oral tolerance induction.
    Wakabayashi A; Kumagai Y; Watari E; Shimizu M; Utsuyama M; Hirokawa K; Takahashi H
    Immunology; 2006 Oct; 119(2):167-77. PubMed ID: 16796692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunostimulatory DNA is a potent mucosal adjuvant.
    Horner AA; Ronaghy A; Cheng PM; Nguyen MD; Cho HJ; Broide D; Raz E
    Cell Immunol; 1998 Nov; 190(1):77-82. PubMed ID: 9826449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Direct interaction between cholera toxin and dendritic cells is required for oral adjuvant activity.
    Gustafsson T; Hua YJ; Dahlgren MW; Livingston M; Johansson-Lindbom B; Yrlid U
    Eur J Immunol; 2013 Jul; 43(7):1779-88. PubMed ID: 23649516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The mucosal adjuvant effects of cholera toxin and immune-stimulating complexes differ in their requirement for IL-12, indicating different pathways of action.
    Grdic D; Smith R; Donachie A; Kjerrulf M; Hörnquist E; Mowat A; Lycke N
    Eur J Immunol; 1999 Jun; 29(6):1774-84. PubMed ID: 10382739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimization of epicutaneous immunization for the induction of CTL.
    Kahlon R; Hu Y; Orteu CH; Kifayet A; Trudeau JD; Tan R; Dutz JP
    Vaccine; 2003 Jun; 21(21-22):2890-9. PubMed ID: 12798632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Zonula occludens toxin acts as an adjuvant through different mucosal routes and induces protective immune responses.
    Marinaro M; Fasano A; De Magistris MT
    Infect Immun; 2003 Apr; 71(4):1897-902. PubMed ID: 12654806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cholera toxin as a mucosal adjuvant: III. Antibody responses to nontarget dietary antigens are not increased.
    Nedrud JG; Sigmund N
    Reg Immunol; 1990-1991; 3(5):217-22. PubMed ID: 1966580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens.
    Lycke N; Holmgren J
    Immunology; 1986 Oct; 59(2):301-8. PubMed ID: 3021614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral immunization against respiratory viruses in mice.
    Nedrud J; Sigmund N; Brunschwig E; Lamm M
    Adv Exp Med Biol; 1995; 371B():1595-8. PubMed ID: 7502863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlations between antibody immune responses at different mucosal effector sites are controlled by antigen type and dosage.
    Externest D; Meckelein B; Schmidt MA; Frey A
    Infect Immun; 2000 Jul; 68(7):3830-9. PubMed ID: 10858191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral administration of cholera toxin-Sendai virus conjugate potentiates gut and respiratory immunity against Sendai virus.
    Liang XP; Lamm ME; Nedrud JG
    J Immunol; 1988 Sep; 141(5):1495-501. PubMed ID: 2842395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mucosal vaccination and immune responses in the elderly.
    Fujihashi K; Koga T; McGhee JR
    Vaccine; 2000 Feb; 18(16):1675-80. PubMed ID: 10689147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Manipulation of intestinal immune responses against ovalbumin by cholera toxin and its B subunit in mice.
    Van der Heijden PJ; Bianchi AT; Dol M; Pals JW; Stok W; Bokhout BA
    Immunology; 1991 Jan; 72(1):89-93. PubMed ID: 1705237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of an already established tumor growing through activated mucosal CTLs induced by oral administration of tumor antigen with cholera toxin.
    Wakabayashi A; Nakagawa Y; Shimizu M; Moriya K; Nishiyama Y; Takahashi H
    J Immunol; 2008 Mar; 180(6):4000-10. PubMed ID: 18322209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nitric oxide modulation of the immune response against cholera toxin-adjuvated ovalbumin administered by the intranasal route.
    Gamba G; Bonorino P; Gonzalez-Videla R; Benedetti R; Cavalieri H; Courreges MC; Massouh EJ; Benencia F
    Immunol Lett; 2004 Apr; 92(3):245-52. PubMed ID: 15081619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.